NURA BIO
Nura Bio revolutionizes the treatment of neurological diseases with novel, life-changing neuroprotective medicines. Nura Bio was conceived in 2018 by The Column Group and its scientific founders.
NURA BIO
Industry:
Biotechnology Health Care Medical Wellness
Founded:
2018-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.nurabio.com
Total Employee:
11+
Status:
Active
Total Funding:
73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Samsara BioCapital
Samsara BioCapital investment in Series A - Nura Bio
Euclidean Capital
Euclidean Capital investment in Series A - Nura Bio
The Column Group
The Column Group investment in Series A - Nura Bio
More informations about "Nura Bio"
Home | Nura Bioâ„¢
A world where the diagnosis of a neurological disorder comes with the hope of a cure. We seek to alter the course of neurological diseases by targeting fundamental pathways underlying axon …See details»
About Us - Nura Bio
Nov 19, 2024 · Nura Bio was conceived in 2018 by The Column Group and its scientific founders to revolutionize the treatment of neurological diseases with novel, life-changing neuroprotective medicines. Breaking new ground for …See details»
Nura Bio Closes Series A Financing with $68 Million in New Funds ...
Sep 17, 2024 · South San Francisco, Calif., September 17, 2024 (BUSINESS WIRE) – Nura Bio Inc. (Nura Bio), a clinical-stage, biopharmaceutical company developing neuroprotective, small …See details»
Nura Bio - LinkedIn
At Nura Bio (previously known as Proneurotech Inc.), we envision a world where the diagnosis of a neurological disorder comes with the hope of a cure.See details»
Nura Bio Closes Series A Financing with $68 Million in New Funds ...
Sep 17, 2024 · SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)--Nura Bio Inc. (Nura Bio), a clinical-stage, biopharmaceutical company developing neuroprotective, small molecule …See details»
Nura Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Nura Bio is a clinical-stage biopharmaceutical company focused on developing neuroprotective therapies to treat neurological diseases. Nura Bio’s drug candidate, NB-4746, is designed …See details»
Nura Bio Company Profile 2024: Valuation, Funding
Developer of transformative neuroprotective therapies designed to prevent and protect against neuronal loss and related neuroimmune dysregulation.See details»
Nura Bio gets $68M, new CEO to advance ‘neuroprotective’ brain …
Sep 17, 2024 · Nura Bio, a private biotechnology company developing small molecule drugs for neurodegenerative conditions, has nearly doubled the size of its Series A round and named a …See details»
Nura Bio Launches to Discover and Develop
Jul 29, 2020 · We're excited to unveil Nura Bio, a biotech company seeking to alter the course of serious neurological diseases by pioneering neuroprotective therapies. We envision a world where the diagnosis...See details»
Nura Bio Initiates Phase I Clinical Trial for its Oral, Brain …
Aug 25, 2023 · Nura Bio, Inc. (Nura Bio) is a clinical-stage biopharmaceutical company developing neuroprotective therapies for the treatment of a broad range of neurological diseases. Nura Bio’s research...See details»
Nura Bio Launches to Discover and Develop Neuroprotective
Jul 29, 2020 · Nura Bio seeks to alter the course of neurological disease by targeting the fundamental pathways underlying axon degeneration and neuroimmune regulation to preserve …See details»
Nura Bio Closes Series A Financing with $68 Million in New
Sep 17, 2024 · SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)--Nura Bio Inc. (Nura Bio), a clinical-stage, biopharmaceutical company developing neuroprotective, small molecule …See details»
Nura Bio Launches to Discover and Develop Neuroprotective …
Jul 29, 2020 · South San Francisco, Calif., July 29, 2020 (Business Wire) – Nura Bio Inc., a biopharma company created to discover and develop life-changing neuroprotective drugs, …See details»
Nura Bio Secures $140M in Series A Financing and Appoints Shilpa ...
Sep 19, 2024 · “Under Shilpa’s leadership, Nura Bio has successfully transitioned to a clinical-stage organization, making remarkable progress in identifying ways to translate complex …See details»
NuraBio secures $140m to advance neuroprotective drug …
Sep 25, 2024 · Nura Bio has successfully raised an additional $68 million in its series A financing, bringing the total to $140 million. The funding round was led by The Column Group, with …See details»
Experimental MS therapy NB-4746 to be tested in healthy volunteers
Aug 31, 2023 · Nura Bio has launched a Phase 1 clinical trial evaluating NB-4746, its investigational treatment for multiple sclerosis (MS) and several other neurological conditions, …See details»
Nura Bio secures $140M to advance lead drug to next trials
Sep 19, 2024 · Nura Bio has announced the addition of $68 million to its series A financing, closing the round with a total of $140 million. The investment was led by The Column Group …See details»
SHILPA SAMBASHIVAN, PhD | Nura Bioâ„¢
Shilpa is the Chief Executive Officer of Nura Bio. Previously, as the Chief Scientific Officer and founding scientific leader at the company, she led the establishment of Nura Bio’s bespoke …See details»
Join Us - Nura Bio
Join us as we strive for a world where debilitating neurological diseases will be overcome with our transformative neuroprotective medicines. Why Join Nura Bio? At Nura Bio, we envision a …See details»
News and Literature - Nura Bio
Sep 17, 2024 · Nura Bio is pursuing exciting and rapidly evolving science. See our latest news and relevant research in this field.See details»